Skip to content

Comparison of the effect of pomegranate juice with sildenafil in the treatment of intrauterine growth restriction

Comparison of the effect of pomegranate juice with sildenafil on Doppler ultrasound findings in growth restricted fetus

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210730052014N1
Enrollment
54
Registered
2021-10-22
Start date
2021-09-21
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal growth restriction. Maternal care for known or suspected poor fetal growth

Interventions

Intervention 1: One group, in addition to performing the necessary measures given in the obstetrics and gynecology texts (such as advising to rest, ensuring a proper diet, and receiving aspirin), is g

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: No underlying diseases gestational age 26 to 32 weeks fetal developmental delay singleton cases willingness to participate in the study

Exclusion criteria

Exclusion criteria: fetal anomalies and fetal heart problems consumption of antioxidants and special diets

Design outcomes

Secondary

MeasureTime frame
Birth weight of the baby. Timepoint: At birth. Method of measurement: Using digital scales.;Apgar score. Timepoint: At birth. Method of measurement: cheaklist.

Primary

MeasureTime frame
Fetal growth restriction. Timepoint: At the beginning of the study and then monthly. Method of measurement: Changes in umbilical artery PI, uterine artery PI, and estimated fetal weight (FEW) in both groups are monitored and compared monthly by a female resident alongside a perinatologist and radiologist with a Medison device.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactfatemeh qaedi

Arak University of Medical Sciences

qaediftm@gmail.com+98 86 3277 4001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026